Investigation of the ubiquitin-specific protease UBP41 and of the lysosomal cysteine proteases cathepsin-L and cathepsin-B as potential mediators of proapoptotic signalling

Two projects are described within the scope of this thesis. The first project characterizes the ubiquitin-specific protease UBP41 as a protein which upon overexpression causes apoptosis induction in several mammalian cancer cell lines. The second project investigates a possible involvement of the lysosomal cysteine proteases cathepsin-L and cathepsin-B in apoptosis pathways induced by distinct death stimuli, in particular by the tumor necrosis factor a (TNF-a). Therefore, both projects examine a possible regulation of apoptosis induction by proteases that are part of one of the two major systems of protein degradation. UBP41 as a protease with deubiquitylating activity is expected to play a role in the ubiquitin/proteasome system which is the major proteolytic apparatus for the degradation of cytosolic proteins. Cathepsins, on the other hand, are lysosomal proteases that participate in the breakdown of membrane-associated proteins and of extracellular proteins that are taken up by endocytosis. Both, the ubiquitin/proteasome system as well as lysosomal proteases have been previously implicated in the regulation and mediation of apoptosis, and it therefore appeared particularly attractive to further study the effect of UBP41 and cathepsins on cell death signalling in more detail.Mittels eines genetischen cDNA Screening-Verfahren wurden neuartige, bislang noch nicht identifizierte dominant proapoptotische Faktoren isoliert. Darunter war ein cDNA Klon, welcher für die Ubiquitin-spezifische Protease UBP41 kodierte, sowie ein weiterer cDNA Klon, welcher für die lysosomale Protease Cathepsin-L kodierte. Es wurden im weiteren der proapoptotische Effekt von UBP41 sowie der mögliche Zusammenhang zwischen Cathepsin-Expressionsleveln und der Sensitiviät von Tumorzellen gegenüber Apoptose-Induktion studiert. Die Dissertation leistet einen Beitrag zu der in der aktuellen Apoptoseforschung intensiv diskutierten Fragestellung, ob und auf welche Weise Nicht-Caspase Cystein-Proteasen einen Einfluss auf die Vermittlung apoptotischer Signalwege haben

Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis

CD40, a member of the tumor necrosis factor (TNF) receptor family, plays an essential role in T cell–dependent immune responses. Because CD40 is widely expressed on the surface of tumor cells in various B cell malignancies, deregulated CD40 signaling has been suggested to contribute to lymphomagenesis. In this study, we show that B cell-specific expression of a constitutively active CD40 receptor, in the form of a latent membrane protein 1 (LMP1)/CD40 chimeric protein, promoted an increase in the number of follicular and marginal zone B cells in secondary lymphoid organs in transgenic mice. The B cells displayed an activated phenotype, prolonged survival and increased proliferation, but were significantly impaired in T cell-dependent immune responses. Constitutive CD40 signaling in B cells induced selective and constitutive activation of the noncanonical NF-κB pathway and the mitogen-activated protein kinases Jnk and extracellular signal–regulated kinase. LMP1/CD40-expressing mice older than 12 mo developed B cell lymphomas of mono- or oligoclonal origin at high incidence, thus showing that the interplay of the signaling pathways induced by constitutive CD40 signaling is sufficient to initiate a tumorigenic process, ultimately leading to the development of B cell lymphomas

Clec12a Is an Inhibitory Receptor for Uric Acid Crystals that Regulates Inflammation in Response to Cell Death

SummaryRecognition of cell death by the innate immune system triggers inflammatory responses. However, how these reactions are regulated is not well understood. Here, we identify the inhibitory C-type lectin receptor Clec12a as a specific receptor for dead cells. Both human and mouse Clec12a could physically sense uric acid crystals (monosodium urate, MSU), which are key danger signals for cell-death-induced immunity. Clec12a inhibited inflammatory responses to MSU in vitro, and Clec12a-deficient mice exhibited hyperinflammatory responses after being challenged with MSU or necrotic cells and after radiation-induced thymocyte killing in vivo. Thus, we identified a negative regulatory MSU receptor that controls noninfectious inflammation in response to cell death that has implications for autoimmunity and inflammatory disease

Alternative splicing of MALT1 controls signalling and activation of CD4+ T cells

MALT1 channels proximal T-cell receptor (TCR) signalling to downstream signalling pathways. With MALT1A and MALT1B two conserved splice variants exist and we demonstrate here that MALT1 alternative splicing supports optimal T-cell activation. Inclusion of exon7 in MALT1A facilitates the recruitment of TRAF6, which augments MALT1 scaffolding function, but not protease activity. Naive CD4+ T cells express almost exclusively MALT1B and MALT1A expression is induced by TCR stimulation. We identify hnRNP U as a suppressor of exon7 inclusion. Whereas selective depletion of MALT1A impairs T-cell signalling and activation, downregulation of hnRNP U enhances MALT1A expression and T-cell activation. Thus, TCR-induced alternative splicing augments MALT1 scaffolding to enhance downstream signalling and to promote optimal T-cell activation

The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma

Peripheral T cell lymphomas (PTCLs) are highly aggressive malignancies with poor prognosis. Their molecular pathogenesis is not well understood and small animal models for the disease are lacking. Recently, the chromosomal translocation t(5;9)(q33;q22) generating the interleukin-2 (IL-2)–inducible T cell kinase (ITK)–spleen tyrosine kinase (SYK) fusion tyrosine kinase was identified as a recurrent event in PTCL. We show that ITK-SYK associates constitutively with lipid rafts in T cells and triggers antigen-independent phosphorylation of T cell receptor (TCR)–proximal proteins. These events lead to activation of downstream pathways and acute cellular outcomes that correspond to regular TCR ligation, including up-regulation of CD69 or production of IL-2 in vitro or deletion of thymocytes and activation of peripheral T cells in vivo. Ultimately, conditional expression of patient-derived ITK-SYK in mice induces highly malignant PTCLs with 100% penetrance that resemble the human disease. Our work demonstrates that constitutively enforced antigen receptor signaling can, in principle, act as a powerful oncogenic driver. Moreover, we establish a robust clinically relevant and genetically tractable model of human PTCL

Human immune disorder associated with homozygous hypomorphic mutation affecting MALT1B splice variant

Seeholzer, Thomas/0000-0002-1115-3358; Gewies, Andreas/0000-0002-7606-6482WOS:000616665800049PubMed: 32858082[No Abstract Available]Jeffrey Modell Foundation; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 1054/A04, SFB 1335/P07]We thank Caspar Ohnmacht for technical support. Our work in Turkey was supported by the Jeffrey Modell Foundation. The work by D.K. was supported by the Deutsche Forschungsgemeinschaft (grants SFB 1054/A04 and SFB 1335/P07)